A detailed history of Wms Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wms Partners, LLC holds 48,246 shares of PFE stock, worth $1.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
48,246
Previous 47,824 0.88%
Holding current value
$1.4 Million
Previous $1.38 Million 2.76%
% of portfolio
0.1%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $10,925 - $12,546
422 Added 0.88%
48,246 $1.34 Million
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $140,945 - $183,072
-5,394 Reduced 10.14%
47,824 $1.38 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $27,501 - $32,146
-857 Reduced 1.58%
53,218 $1.77 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $16,579 - $19,181
-459 Reduced 0.84%
54,075 $1.98 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $44,392 - $57,792
1,127 Added 2.11%
54,534 $2.22 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $361,262 - $471,588
-8,653 Reduced 13.94%
53,407 $2.74 Million
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $63,320 - $77,298
-1,447 Reduced 2.28%
62,060 $2.72 Million
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $44,110 - $52,301
948 Added 1.52%
63,507 $3.33 Million
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $216,855 - $268,710
4,740 Added 8.2%
62,559 $3.24 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $30,411 - $45,080
-736 Reduced 1.26%
57,819 $3.41 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $353 - $453
9 Added 0.02%
58,555 $2.52 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $43,738 - $49,548
-1,218 Reduced 2.04%
58,546 $2.29 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $56,698 - $63,944
1,693 Added 2.92%
59,764 $2.17 Million
Q4 2020

Feb 17, 2021

SELL
$33.47 - $42.56 $111,120 - $141,299
-3,320 Reduced 5.41%
58,071 $2.14 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $2,032 - $2,384
64 Added 0.1%
61,391 $2.25 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $9,879 - $11,985
-328 Reduced 0.53%
61,327 $2.01 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $117,688 - $168,151
-4,354 Reduced 6.6%
61,655 $2.01 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $211,543 - $240,075
-6,426 Reduced 8.87%
66,009 $2.59 Million
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $6,790 - $8,805
-209 Reduced 0.29%
72,435 $2.6 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $256,123 - $287,567
6,926 Added 10.54%
72,644 $3.15 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $4,837 - $5,314
-129 Reduced 0.2%
65,718 $2.79 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $366,465 - $417,810
9,526 Added 16.91%
65,847 $2.87 Million
Q3 2018

Nov 08, 2018

SELL
$34.47 - $41.81 $52,532 - $63,718
-1,524 Reduced 2.63%
56,321 $2.48 Million
Q2 2018

Aug 09, 2018

SELL
$32.98 - $35.16 $67,246 - $71,691
-2,039 Reduced 3.4%
57,845 $2.1 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $11,328 - $13,142
-355 Reduced 0.59%
59,884 $2.13 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $31,530 - $33,454
948 Added 1.6%
60,239 $2.18 Million
Q3 2017

Oct 27, 2017

BUY
$31.0 - $34.15 $13,330 - $14,684
430 Added 0.73%
59,291 $2.12 Million
Q2 2017

Aug 09, 2017

BUY
N/A
58,861
58,861 $1.98 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wms Partners, LLC Portfolio

Follow Wms Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.